financetom
Business
financetom
/
Business
/
Universal Health Services' higher expenses weigh on third-quarter profit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Universal Health Services' higher expenses weigh on third-quarter profit
Oct 26, 2024 12:01 AM

Oct 24 (Reuters) - Hospital operator Universal Health

Services ( UHS ) reported on Thursday its third-quarter profit

in line with Wall Street estimates, hurt by increased expenses,

such as salaries and wages for its staff.

Shares of the company fell nearly 8% to $207 after the

bell.

Expenses on salaries, wages and benefits rose 7% to $1.9

billion for the third quarter and overall operating charges rose

9.2% to $3.6 billion.

Quarterly same facility adjusted admissions increased by

1.5% at its acute care hospitals, while same facility adjusted

admissions were up 2.2% at the behavioral health care

facilities, as more patients sought medical care that required

hospital stay.

Hospital operators have been benefiting from an uptick in

demand for medical care, as older adults are catching up on

surgeries delayed during the pandemic.

The King of Prussia, Pennsylvania-based company posted an

adjusted profit of $3.71 per share for the quarter ended Sept.

30, compared with analysts' estimates of $3.70 per share,

according to data compiled by LSEG.

Universal Health had previously forecast 2024 profit in

the range of $15.40 to $16.20 per share and revenues of $15.57

billion to $15.75 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ClearPoint Gets FDA Clearance For Neurosurgical Equipment
ClearPoint Gets FDA Clearance For Neurosurgical Equipment
Apr 29, 2024
03:08 PM EDT, 04/29/2024 (MT Newswires) -- ClearPoint Neuro ( CLPT ) said Monday it received 510(k) approval from the US Food and Drug Administration for its Prism Bone Anchor Accessory. The Prism Bone Anchor Accessory is designed for use with stereotactic systems in intracranial and neurosurgical procedures, offering precise positioning of small surgical instruments in the cranium, brain, or...
WeWork reaches settlement with creditors, rebuffs Neumann bid
WeWork reaches settlement with creditors, rebuffs Neumann bid
Apr 29, 2024
NEW YORK, April 29 (Reuters) - Shared office space provider WeWork ( WEWOQ ) announced on Monday a settlement with its junior creditors and a new cash infusion from its senior lenders, moving ahead with a bankruptcy deal that rejects a $650 million offer from co-founder and former owner Adam Neumann. During a hearing in Newark, New Jersey, U.S. Bankruptcy...
SS&C Technologies Unit to Borrow up to $2.78 Billion Loan
SS&C Technologies Unit to Borrow up to $2.78 Billion Loan
Apr 29, 2024
03:20 PM EDT, 04/29/2024 (MT Newswires) -- SS&C Technologies Holdings ( SSNC ) said Monday it plans to borrow up to $2.78 billion in incremental term B-8 loans for one of its subsidiaries. The loans will be issued under the amended credit agreement, dated April 16, 2018, with SS&C Financing, SS&C European Holdings SARL, and SS&C Technologies Holdings Europe SARL,...
Cullinan Therapeutics Appoints Mary Kay Fenton as CFO
Cullinan Therapeutics Appoints Mary Kay Fenton as CFO
Apr 29, 2024
03:19 PM EDT, 04/29/2024 (MT Newswires) -- Cullinan Therapeutics ( CGEM ) said Monday it has appointed Mary Kay Fenton as chief financial officer, effective immediately. Fenton has thirty years of financial and operational experience in the biotechnology industry, recently serving as interim chief executive officer and CFO of Talaris Therapeutics, the company said. Shares of the company rose 7.2%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved